Seidel W F, Cohen S A, Wilson L, Dement W C
Psychopharmacology (Berl). 1985;87(2):194-7. doi: 10.1007/BF00431806.
Eighteen non-anxious volunteers underwent sleep recordings and daytime tests of sleepiness, performance, and mood while receiving, either alprazolam 0.5 mg b.i.d. or diazepam 5 mg b.i.d. for 7 consecutive days. Recordings and tests were done before treatment and on the 1st and 7th days of treatment. Nocturnal sleep changes were similar for both groups; there were no statistically significant changes in mood. However, levels of daytime sleepiness differed. Alprazolam subjects showed more daytime sedation than diazepam subjects on treatment day 1, but showed a significant decrease in Day 1-7 daytime sedation. Although diazepam subjects were less sedated at the onset, they showed no tolerance to this effect; thus by treatment day 7, the two groups did not differ in levels of daytime sleepiness. Results suggested that tolerance to alprazolam's sedative effects (which develops during the 1st week of treatment) may be separable from tolerance to its antianxiety effects (which develops after at least 4 weeks). As daytime sedation is common and potentially dangerous with most anxiolytics, selective tolerance to this side effect is highly desirable.
18名无焦虑症状的志愿者接受了睡眠记录以及日间嗜睡、行为表现和情绪测试,同时连续7天每日两次分别服用0.5毫克阿普唑仑或5毫克地西泮。记录和测试在治疗前以及治疗的第1天和第7天进行。两组的夜间睡眠变化相似;情绪方面无统计学显著变化。然而,日间嗜睡程度有所不同。在治疗第1天,服用阿普唑仑的受试者比服用地西泮的受试者表现出更多的日间镇静作用,但在第1至7天日间镇静作用显著降低。虽然服用地西泮的受试者在开始时镇静作用较轻,但他们并未对这种作用产生耐受性;因此到治疗第7天,两组在日间嗜睡程度上没有差异。结果表明,对阿普唑仑镇静作用的耐受性(在治疗的第1周内产生)可能与其抗焦虑作用的耐受性(至少在4周后产生)是可分离的。由于大多数抗焦虑药都会出现常见且有潜在危险的日间镇静作用,因此对这种副作用的选择性耐受性是非常可取的。